A critical area of investigation is the identification of specific genetic alterations that contribute to the development of pediatric lipomas, such as those involving the loci 12q14–15 and 6p21, which are known to lead to the overexpression of genes like HMGA2 and HMGA1 [18]. The gene discussed is HMGA1; the disease is lipoma.